Drug Shortage Report for TOBRAMYCIN FOR INJECTION
Report ID | 170887 |
Drug Identification Number | 00533688 |
Brand name | TOBRAMYCIN FOR INJECTION |
Common or Proper name | TOBRAMYCIN FOR INJECTION |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | TOBRAMYCIN |
Strength(s) | 1.2G |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 50 mL |
ATC code | J01GB |
ATC description | AMINOGLYCOSIDE ANTIBACTERIALS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2022-09-20 |
Estimated end date | 2023-09-27 |
Actual end date | 2023-09-26 |
Shortage status | Resolved |
Updated date | 2023-09-27 |
Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be extending the backorder on our Tobramycin for Injection, 1.2 g PBP Vial 50 mL until September 27, 2023. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2023-09-27 | English | Compare |
v16 | 2023-09-26 | French | Compare |
v15 | 2023-09-26 | English | Compare |
v14 | 2023-09-06 | French | Compare |
v13 | 2023-09-06 | English | Compare |
v12 | 2023-09-06 | French | Compare |
v11 | 2023-09-06 | English | Compare |
v10 | 2023-08-11 | French | Compare |
v9 | 2023-08-11 | English | Compare |
v8 | 2023-06-14 | French | Compare |
v7 | 2023-06-14 | English | Compare |
v6 | 2023-06-01 | French | Compare |
v5 | 2023-06-01 | English | Compare |
v4 | 2022-12-05 | French | Compare |
v3 | 2022-12-05 | English | Compare |
v2 | 2022-10-02 | French | Compare |
v1 | 2022-10-02 | English | Compare |
Showing 1 to 17 of 17